December
27, 2001
Gainesville Sun
Voters
in California and Arizona touched off a national debate five years
ago, when they approved amendments to legalize marijuana use for medical
purposes; to relieve patients of pain and suffering. In reaction,
the federal government took steps to prevent doctors in those states
from prescribing marijuana as a pain-controller and cracked down on
"medical pot clubs" in California.
But
that probably won't prevent medical marijuana initiatives from taking
root in other states.
The
official position of the National Institutes of Health is that there
is little evidence to show that marijuana really has value as medicine.
But that bottom line comes with a qualification; to wit, there really
aren't a lot of studies out there to either prove or disprove the contention
that smoking marijuana can be faster and more effective than many prescription
medicines in easing the pain of patients suffering from cancer, AIDS
or a wide range of other diseases. Most of the evidence is anecdotal.
In
fact, there have been virtually no federally sanctioned studies on
the subject since the early 1980s. Because the federal government
controls all of the legally grown marijuana in America, and because
a number of federal agencies must sign off on such studies, researchers
have not exactly been aggressive in seeking out authorization.
But
that may be changing. The Drug Enforcement Administration has recently
approved two medical marijuana studies and is in the process of sanctioning
a third. All three will be conducted by universities in California.
Two of the studies will try to determine if smoking marijuana can
effectively relieve pain in multiple sclerosis patients, while a third
will look at the drug's efficacy in treating a condition common to
HIV patients that causes severe pain in the hands and feet.
"This
is not much yet, but it is a recognition by the federal government
that it cannot prevent all work from going forward," Paul Armentano,
of the National Organization for the Reform of Marijuana Laws, told
the New York Times recently.
It's
clear that the debate over the use of medical marijuana isn't going
to go away. Advocacy groups like NORML will continue to support citizens
initiatives. And if California and Arizona results are any example,
voters appear to be sympathetic to the idea of allowing marijuana
use for medical purposes. For their part, officials who take a hard
line against drugs cannot simply continue to argue in dogmatic fashion
that marijuana has no medical value. In the absence of scientific
evidence one way or another, such arguments will ultimately lose credibility.
In
short, ignorance is not bliss in regard to the issue of medical marijuana.
The more researchers learn about the potential medicinal value of
marijuana, the better. Whether its made by citizen initiative or via
the legislative process, public health policy should not fashioned
without benefit of all the factual evidence that can be mustered.
Critics
say the dearth of research on the medicinal properties of marijuana
over the past two decades has been the result of a "de facto" ban
on marijuana studies. Whether that's true or not, it is appropriate
to move forward with appropriate studies.